Development and testing of preclinical models and biodegradable materials for immunotherapy
 
WP3 aims to refine and further develop immune competent in vivo models to study immune function, develop new in vivo assays and novel biomaterial formats that will be relevant for in vivo monitoring and combined immunotherapy. This will include refinement of humanised mouse models for PDX, development of optical imaging moieties and in vivo multi-coloured tracking of T-cells and MQs.

Our objectives are as follows:
3.1: Develop new tools to study aberrant immune function based on finding from WP1,
3.2: Develop new biomaterial-based particles for immunotherapy and imaging of immune function.

Overview of all packages...